This topic contains a solution. Click here to go to the answer

Author Question: A 0.500-kg ball traveling horizontally on a frictionless surface approaches a very massive stone at ... (Read 122 times)

corkyiscool3328

  • Hero Member
  • *****
  • Posts: 539
A 0.500-kg ball traveling horizontally on a frictionless surface approaches a very massive stone at 20.0 m/s perpendicular to wall and rebounds with 70.0 of its initial kinetic energy. What is the magnitude of the change in momentum of the stone?
 
  A) 18.4 kgm/s
  B) 14.0 kgm/s
  C) 3.00 kgm/s
  D) 1.63 kgm/s
  E) 0.000 kgm/s

Question 2

What is the temperature of 3.0 moles of gas at a pressure of 250 kPa held in a volume of 15 L?
 
  A) 150 K
  B) 200 K
  C) 250 K
  D) 300 K
  E) 350 K



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

isabelt_18

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

A

Answer to Question 2

A




corkyiscool3328

  • Member
  • Posts: 539
Reply 2 on: Jul 29, 2018
Thanks for the timely response, appreciate it


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library